Associations of Leukocyte-Derived Chemotaxin-2 (LECT2) with Insulin Resistance and Metabolic Syndrome in Type 2 Diabetes: A Cross-Sectional Study

Yujing Sha,* Jiaping Lu,* Rui Jin, Lian Li, Min Zhang Department of Endocrinology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, 201700, People’s Republic of China*These authors contributed equally to this workCorrespondence: Min Zh...

Full description

Saved in:
Bibliographic Details
Main Authors: Sha Y, Lu J, Jin R, Li L, Zhang M
Format: Article
Language:English
Published: Dove Medical Press 2025-07-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/associations-of-leukocyte-derived-chemotaxin-2-lect2-with-insulin-resi-peer-reviewed-fulltext-article-DMSO
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849703215026667520
author Sha Y
Lu J
Jin R
Li L
Zhang M
author_facet Sha Y
Lu J
Jin R
Li L
Zhang M
author_sort Sha Y
collection DOAJ
description Yujing Sha,* Jiaping Lu,* Rui Jin, Lian Li, Min Zhang Department of Endocrinology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, 201700, People’s Republic of China*These authors contributed equally to this workCorrespondence: Min Zhang, Department of Endocrinology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, N0.1158 of East Gongyuan Road, Qingpu District, Shanghai, 201700, People’s Republic of China, Tel +86 18116016187, Email 18116016187@163.comObjective: Leukocyte-derived chemokine-2 (LECT2) is a novel neutrophil chemokine synthesized by the liver. This research aimed to investigate the potential link between LECT2 levels and metabolic syndrome (MetS) as well as insulin resistance (IR) in patients with type 2 diabetes mellitus (T2D). The results could offer fresh perspectives on the diagnosis and therapeutic strategies for T2D and associated metabolic disorders.Methods: A cross-sectional study was conducted on 148 T2D patients, including 90 with MetS and 58 without MetS. The diagnosis of MetS was based on the standardized guidelines established by the International Diabetes Federation. IR was assessed via HOMA-IR, with a cutoff of ≥ 2.69. Serum LECT2 levels were measured using ELISA.Results: In T2D patients, individuals with MetS exhibited significantly higher LECT2 levels than the non-MetS group (1.73± 0.31 ng/mL vs 1.55± 0.33 ng/mL, P< 0.05). In addition, LECT2 concentrations were significantly elevated in the IR group compared to the N-IR group (1.75 ± 0.33 ng/mL vs 1.61± 0.32ng/mL, P< 0.05). Higher LECT2 levels were linked to increased metabolic dysfunction, as reflected by elevated FPG, FINS, HOMA-IR, and TG levels. Multivariable logistic regression analysis demonstrated that, after adjusting for multiple confounding factors, LECT2 still exhibits a significant association with the occurrence of MetS (OR=8.48, P=0.01).Conclusion: LECT2 concentrations were elevated in T2D patients combined with MetS and were significantly related to IR. These results indicate that LECT2 could contribute to the pathogenesis of T2D accompanied by MetS, and LECT2 may represent a promising therapeutic target for MetS and its related metabolic disturbances.Keywords: leukocyte-derived chemokine-2, metabolic syndrome, diabetes mellitus, type 2, insulin resistance
format Article
id doaj-art-158a98f24e07465eb97bb0e12cc64186
institution DOAJ
issn 1178-7007
language English
publishDate 2025-07-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj-art-158a98f24e07465eb97bb0e12cc641862025-08-20T03:17:22ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072025-07-01Volume 18Issue 121312140104496Associations of Leukocyte-Derived Chemotaxin-2 (LECT2) with Insulin Resistance and Metabolic Syndrome in Type 2 Diabetes: A Cross-Sectional StudySha Y0Lu J1Jin R2Li L3Zhang M4Department of EndocrinologyDepartment of EndocrinologyDepartment of EndocrinologyDepartment of EndocrinologyDepartment of EndocrinologyYujing Sha,* Jiaping Lu,* Rui Jin, Lian Li, Min Zhang Department of Endocrinology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, 201700, People’s Republic of China*These authors contributed equally to this workCorrespondence: Min Zhang, Department of Endocrinology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, N0.1158 of East Gongyuan Road, Qingpu District, Shanghai, 201700, People’s Republic of China, Tel +86 18116016187, Email 18116016187@163.comObjective: Leukocyte-derived chemokine-2 (LECT2) is a novel neutrophil chemokine synthesized by the liver. This research aimed to investigate the potential link between LECT2 levels and metabolic syndrome (MetS) as well as insulin resistance (IR) in patients with type 2 diabetes mellitus (T2D). The results could offer fresh perspectives on the diagnosis and therapeutic strategies for T2D and associated metabolic disorders.Methods: A cross-sectional study was conducted on 148 T2D patients, including 90 with MetS and 58 without MetS. The diagnosis of MetS was based on the standardized guidelines established by the International Diabetes Federation. IR was assessed via HOMA-IR, with a cutoff of ≥ 2.69. Serum LECT2 levels were measured using ELISA.Results: In T2D patients, individuals with MetS exhibited significantly higher LECT2 levels than the non-MetS group (1.73± 0.31 ng/mL vs 1.55± 0.33 ng/mL, P< 0.05). In addition, LECT2 concentrations were significantly elevated in the IR group compared to the N-IR group (1.75 ± 0.33 ng/mL vs 1.61± 0.32ng/mL, P< 0.05). Higher LECT2 levels were linked to increased metabolic dysfunction, as reflected by elevated FPG, FINS, HOMA-IR, and TG levels. Multivariable logistic regression analysis demonstrated that, after adjusting for multiple confounding factors, LECT2 still exhibits a significant association with the occurrence of MetS (OR=8.48, P=0.01).Conclusion: LECT2 concentrations were elevated in T2D patients combined with MetS and were significantly related to IR. These results indicate that LECT2 could contribute to the pathogenesis of T2D accompanied by MetS, and LECT2 may represent a promising therapeutic target for MetS and its related metabolic disturbances.Keywords: leukocyte-derived chemokine-2, metabolic syndrome, diabetes mellitus, type 2, insulin resistancehttps://www.dovepress.com/associations-of-leukocyte-derived-chemotaxin-2-lect2-with-insulin-resi-peer-reviewed-fulltext-article-DMSOLeukocyte-derived chemokine-2Metabolic SyndromeDiabetes MellitusType 2Insulin Resistance
spellingShingle Sha Y
Lu J
Jin R
Li L
Zhang M
Associations of Leukocyte-Derived Chemotaxin-2 (LECT2) with Insulin Resistance and Metabolic Syndrome in Type 2 Diabetes: A Cross-Sectional Study
Diabetes, Metabolic Syndrome and Obesity
Leukocyte-derived chemokine-2
Metabolic Syndrome
Diabetes Mellitus
Type 2
Insulin Resistance
title Associations of Leukocyte-Derived Chemotaxin-2 (LECT2) with Insulin Resistance and Metabolic Syndrome in Type 2 Diabetes: A Cross-Sectional Study
title_full Associations of Leukocyte-Derived Chemotaxin-2 (LECT2) with Insulin Resistance and Metabolic Syndrome in Type 2 Diabetes: A Cross-Sectional Study
title_fullStr Associations of Leukocyte-Derived Chemotaxin-2 (LECT2) with Insulin Resistance and Metabolic Syndrome in Type 2 Diabetes: A Cross-Sectional Study
title_full_unstemmed Associations of Leukocyte-Derived Chemotaxin-2 (LECT2) with Insulin Resistance and Metabolic Syndrome in Type 2 Diabetes: A Cross-Sectional Study
title_short Associations of Leukocyte-Derived Chemotaxin-2 (LECT2) with Insulin Resistance and Metabolic Syndrome in Type 2 Diabetes: A Cross-Sectional Study
title_sort associations of leukocyte derived chemotaxin 2 lect2 with insulin resistance and metabolic syndrome in type 2 diabetes a cross sectional study
topic Leukocyte-derived chemokine-2
Metabolic Syndrome
Diabetes Mellitus
Type 2
Insulin Resistance
url https://www.dovepress.com/associations-of-leukocyte-derived-chemotaxin-2-lect2-with-insulin-resi-peer-reviewed-fulltext-article-DMSO
work_keys_str_mv AT shay associationsofleukocytederivedchemotaxin2lect2withinsulinresistanceandmetabolicsyndromeintype2diabetesacrosssectionalstudy
AT luj associationsofleukocytederivedchemotaxin2lect2withinsulinresistanceandmetabolicsyndromeintype2diabetesacrosssectionalstudy
AT jinr associationsofleukocytederivedchemotaxin2lect2withinsulinresistanceandmetabolicsyndromeintype2diabetesacrosssectionalstudy
AT lil associationsofleukocytederivedchemotaxin2lect2withinsulinresistanceandmetabolicsyndromeintype2diabetesacrosssectionalstudy
AT zhangm associationsofleukocytederivedchemotaxin2lect2withinsulinresistanceandmetabolicsyndromeintype2diabetesacrosssectionalstudy